New quality system design/delivery/maintenance, auditing against regional regulatory guidelines (21CFRpart11, GLP, GMP, GCP, GAMP5), quality system audit and recommendations, quality system best practice adoption

Instrument validation strategy, IQ, OQ, PQ qualification, risk-based approaches, execution and reporting across 21 CFR part 11, GLP, GMP, GAMP for all analytical instrument hardware platforms

Early Pharmacology, ADME, Assay Automation, PK/PD, Assay Development & Validation, Bioanalysis, Inventory Management etc. and the linked regulatory aspects of GLP and IND/NDA/BLA creation support.

ERP, Registration, Inventory, ELN, LIMS integration, laboratory instruments & robotics, project planning & lab audit tools, integration layer technology, instrument data standards (ADF, AniML, SiLA etc.), tech blueprints

CDM meeting 21CFR Part 11, EUANNEX Part 11 and GDPR, experience with numerous data analysis/review tools and processes suggested by GCDMP

"Always on", end-user support, proven scale, quality, processes and knowledge of scientific applications have a measurable impact on end-user efficiency, satisfaction and application downtime.

Automated assay and screening, batch release, workflow orchestration, BPMN, low-code-no-code process automation (RPA) and robotics platforms.

Process optimisation, automation, validation and QC through BPMN, technology and change management to automate business rules to support decisions and scale

Assay development and validation, instrument data acquisition and integration, regulatory and QC data reporting, lab inventory and metrology, workflow automation and validation